Home - Products - Angiogenesis - FGFR - FIIN-4

FIIN-4

CAS No. 2093088-81-2

FIIN-4( —— )

Catalog No. M34253 CAS No. 2093088-81-2

FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	299	Get Quote
5MG	455	Get Quote
10MG	620	Get Quote
25MG	911	Get Quote
50MG	1224	Get Quote
100MG	1575	Get Quote
200MG	2133	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

FIIN-4
Note

Research use only, not for human use.
Brief Description

FIIN-4 is a covalent inhibitor of FGFR and can be used in studies about metastatic breast cancer.
Description

FIIN-4 is a small molecule cysteine-targeting covalent kinase inhibitor (CKI).
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

FGFR
Recptor

FGFR
Research Area

——
Indication

——

Chemical Information

CAS Number

2093088-81-2
Formula Weight

634.73
Molecular Formula

C35H38N8O4
Purity

>98% (HPLC)
Solubility

——
SMILES

C(N1C=2C(CN(C1=O)C3=CC(OC)=CC(OC)=C3)=CN=C(NC4=CC=C(C=C4)N5CCN(C)CC5)N2)C6=CC(NC(C=C)=O)=CC=C6
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Vofatamab

Vofatamab (B-701) is a fully human monoclonal antibody targeting FGFR3. Vofatamab has potential anticancer and antitumor activity and is often used in combination with other compounds to treat cancer.
BLU9931

BLU9931 (BLU-9931) is a potent, selective, irreversible inhibitor of FGFR4 with IC50 of 3 nM.
hnps-PLA Inhibitor

Hnps-PLA Inhibitor is an inhibitor of human nonpancreatic secretory Phospholipase A (hnps-PLA).

Sign In Join Free